(Q44309078)

English

Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

object named as

Nathan Clumeck

0 references

author name string

Alain Lafeuillade

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nathan Clumeck

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Josep Mallolas

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hans Jaeger

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jean-Michel Livrozet

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Maria do Sameira Ferreira

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Margaret Johnson

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Arnaud Cheret

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Zeina Antoun

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

European Trizal team

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

37-43

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

Metabolic effects of indinavir in healthy HIV-seronegative men

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

1 reference

https://api.crossref.org/works/10.1310%2FEJRF-JGGH-GRCD-MED8

21 January 2018

Identifiers

10.1310/EJRF-JGGH-GRCD-MED8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44309078&oldid=2109340602"